Inventor · disambiguated record
Alan Glicklich
Also filed as: GLICKLICH ALAN
9 granted patents·3 pending applications·39 citations·filing 2015–2025
87Inventor score
Files withARENA PHARM INC12
Top patents by PatentIndex Score
12 records- 0195US11426377B2Method of treating conditions related to the PGI2 receptorARENA PHARM INC·Filed 2021·Granted Aug 30, 2022·5 cites·22 claims
- 0295US11000500B2Method of treating conditions related to the PGI2 receptorARENA PHARM INC·Filed 2020·Granted May 11, 2021·7 cites·23 claims
- 0392US11826337B2Method of treating conditions related to the PGI2 receptorARENA PHARM INC·Filed 2022·Granted Nov 28, 2023·1 cites·22 claims
- 0491US10688076B2Method of treating conditions related to the PGI2 receptorARENA PHARM INC·Filed 2019·Granted Jun 23, 2020·7 cites·17 claims
- 0591US10537546B2Method of treating conditions related to the PGI2 receptorARENA PHARM INC·Filed 2015·Granted Jan 21, 2020·9 cites·17 claims
- 0689US11007175B2Methods of treating conditions related to the S1P1 receptorARENA PHARM INC·Filed 2016·Granted May 18, 2021·10 cites·21 claims
- 0787US12239627B2Method of treating conditions related to the PGI2 receptorARENA PHARM INC·Filed 2023·Granted Mar 4, 2025·0 cites·11 claims
- 0884US12377071B2Methods of treating conditions related to the S1P1 receptorARENA PHARM INC·Filed 2024·Granted Aug 5, 2025·0 cites·18 claims
- 0983US2023172898A1Method of treating conditions related to the pgi2 receptorARENA PHARM INC·Filed 2023·Application pending·0 cites
- 1079US2025319062A1Methods of treating conditions related to the s1p1 receptorARENA PHARM INC·Filed 2025·Application pending·0 cites
- 1174US2025152549A1Method of treating conditions related to the pgi2 receptorARENA PHARM INC·Filed 2025·Application pending·0 cites
- 1272US11896578B2Methods of treating conditions related to the S1P1 receptorARENA PHARM INC·Filed 2021·Granted Feb 13, 2024·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Alan Glicklich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →